Xiangdan injection

1. Anti-myocardial ischemia: Intravenous injection of 0.8, 1.6, and 3.2 g/kg of this product can reduce the scope of myocardial infarction in dogs with acute myocardial ischemia caused by ligation of the left anterior descending coronary artery, slow down the acceleration of heart rate caused by ischemia, reduce the release of CK, LDH, and MDA in serum, and enhance SOD activity. 2. Effect on hemodynamics: Intravenous injection of 0.26, 0.78, and 2.34 g/kg of this product can significantly increase the coronary flow and cardiac output of anesthetized dogs, reduce femoral artery systolic pressure (SAP), diastolic pressure (DAP), and mean arterial pressure (MAP). 3. Improve blood rheology: Intravenous injection of 4 g/kg of this product can significantly reduce the whole blood viscosity, hematocrit, and platelet aggregation of rats with blood stasis syndrome caused by intravenous injection of glucose saline, and increase the maximum deformation coefficient of red blood cells. 4. Other effects Oral administration of 0.4 and 0.8 g/kg of this product can reduce experimental liver damage in mice caused by galactosamine, reduce the levels of plasma and liver homogenate peroxide (LPO) and malondialdehyde (MDA), and reduce the levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST).

Danshen, Dalbergia odorifera. Auxiliary materials are polysorbate, sodium bisulfite

Intramuscular injection: 2 ml at a time, 1-2 times a day. Intravenous drip: 10-20 ml at a time, diluted with 250-500 ml of 5-10% glucose injection, or as directed by a doctor.

According to literature reports, the use of this product may occasionally cause rash, skin redness and swelling, itching, nausea, vomiting, chills, fever, dizziness, headache, abdominal pain, diarrhea, palpitations, etc. It can cause severe allergic reactions manifested as anaphylactic shock, difficulty breathing, laryngeal edema, etc.

1. Pregnant and lactating women are prohibited from using this product. 2. Those who are allergic to this product are prohibited from using this product. 3. Levofloxacin hydrochloride injection is incompatible with this product.

There is an incompatibility between levofloxacin hydrochloride injection and Xiangdan injection.

Sealed, light-shielding

2ml per bottle

Haoda Pharmaceutical Co., Ltd.

• Founded in:

  2002-08-17

• Address:

  Qiaotou, Xia County, Yuncheng City, Shanxi Province

• Tax NO.:

  9114080074106831X6

• Registered Funds:

  139.798 million yuan

• Email:

  Log in to view